Protective effects of hydrocortisone, vitamin C and E alone or in combination against renal ischemia-reperfusion injury in rat

Iranian Journal of Pathology

Volumn 10, Issue 4, 2015, Pages 272-280

  Azari, Omid ^a   Kheirandish, Reza ^a   Azizi, Shahrzad ^a   Abbasi, Mohammad Farajli ^a   Chaman, Shahin Ghahramani Gareh ^a   Bidi, Masoud ^a  

^a SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

Author keywords

Hydrocortisone; Ischemia; Kidney; Reperfusion; Vitamin C; Vitamin E

Indexed keywords

EID: 84931332174     PISSN: 17355303     EISSN: 23453656     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Mejía-Vilet JM, Ramírez V, Cruz C, Uribe N, Gamba G, Bobadilla NA. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol 2007; 293: 78-86.
2. Lakshmanadoss U. Novel Strategies in Ischemic Heart Disease. Croatia:Tech Europ; 2012
3. Kelly KJ, Molitoris BA. Acute renal failure in the new millennium: time to consider combination therapy. Semin Nephrol 2000; 20: 4-19.
4. Molina A, Ubeda M, Escribese MM, Bermejo LG, Sancho D, Pérez de Lema G, et al. Renal Ischemia/ Reperfusion Injury: Functional Tissue Preservation by Anti-Activated _ Integrin Therapy. J Am Sci Nephrol 2005; 16: 374–382.
5. Chan KL. Role of Nitric Oxide in Ischemia and Reperfusion Injury. Current Medicinal Chemistry -Anti-Inflammatory & Anti-Allergy Agents. 2002; 1(1):1-13.
6. Kosieradzki M, Rowiński W. Ischemia/ reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc 2008; 3279-3288.
7. Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD. Acute Mesenteric Ischemia, A clinical review. Arch Intern Med 2004; 164: 1054-1062.
8. Thiemermann C, Patel NS, Kvale EO, Cockerill GW, Brown PA, Stewart KN, et al. High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury. J Am Sci Nephrol 2003; 14: 1833–1843.
9. Huk I, Brovkovych V, Nanobashvili J, Neumayer C, Polterauer P, Prager M, et al. Prostaglandin E1 reduces ischemia/reperfusion injury by normalizing nitric oxide and superoxide release. Shock 2000; 14: 234–242.
10. Hathcock JN. Vitamin and Mineral Safety. 2nd ed. Washington, DC:CRN; 2004.
11. Lehr HA, Frei B, Olofsson AM, Carew TE, Arfors KE. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation 1995; 91: 1525-1532.
12. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia–reperfusion injury. Cardiovasc Res 2000; 47: 446–456.
13. Jansen NJ, Van Oeveren W, Van Vliet M, Stoutenbeek CP, Eysman L, Wildevuur CR. The role of different types of corticosteroids on the inflammatory mediators of cardiopulmonary bypass. Euro J Cardiothoracic Surg 1991; 5: 211–217.
14. Hur E, Garip A, Camyar A, Ilgun S, Ozisik M, Tuna S, et al. The effects of Vitamin D on Gentamicininduced acute kidney injury in experimental rat model. Int J Endocrin 2013: 1-7.
15. Akinrinmade JF, Akinrinde AS. Effect of Oral Administration of Methanolic Extract of Ocimum gratissimum on Intestinal Ischemia-Reperfusion Injury in Rats. Euro J Med Plants. 2013; 3: 591-602.
16. Lerman L, Textor SC. Pathophysiology of ischemic nephropathy. Urol Clin North Am 2001; 28: 793-803.
17. Yazihan N, Ozelci Kavas G. Protective Effect of Erythropoietin in Renal Ischemia-Reperfusion Injury. Open Drug Discovery J 2010; 2: 3-7.
18. Ahmadiasl1 N, Banaei S, Alihemmati A, Baradaran B, Azimian E. The Anti-Inflammatory Effect of Erythropoietin and Melatonin on Renal Ischemia Reperfusion Injury in Male Rats. Adv Pharm Bull 2014; 4: 49-54.
19. Erkut B, Özyazıcıoğlu A, Karapolat BS, Koçoğullar CU, Keles S, Ateş A, et al. Effects of Ascorbic Acid, Alpha-Tocopherol and Allopurinol on Ischemia-Reperfusion Injury in Rabbit Skeletal Muscle: An Experimental Study. Drug Target Insights 2007; 2: 249-258.
20. Kearns SR, Daly AF, Sheehan K, Murray P, Kelly C, Bouchier-Hayes D. Oral vitamin C reduces the injury to skeletal muscle caused by compartment syndrome. J Bone Joint Surg Br 2004; 86: 906-911.
21. Armour J, Tyml K, Lidlington D, Wilson JX. Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J Appl Physiol 2001; 90: 795–803.
22. Kearns SR, Moneley D, Murray P, et al. Oral vitamin C attenuates acute ischemia-reperfusion injury in skeletal muscle. J Bone Joint Surg Br 2001; 83(8): 1202-1206.
23. Grace P, Mathie R. Ischaemia-Reperfusion Injury. London: Blackwell Science;1999.
24. Derakhshanfar A, Oloumi MM, Esmailzadeh S, Abbasi L, Shamsoddin Saeed M, Amin Sadrabadi E. Histopathological evaluation on the effects of venesection and vitamin C on systemic renal and hepatic lesions after limb ischemia-reperfusion in rabbit. Iran J Vet Surg 2009; 4:95-102.
25. Seo MY, Lee SM. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/ reperfusion in rats. J Hepatol 2002; 36: 72.
26. Niki E. Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am J Clin Nutr 199; 54(6 Suppl): 1119S-1124S.
27. Higa OH, Parra ER, Ab’Saber AM, Farhat C, Higa R, Capelozzi VL. Protective effects of ascorbic acid pretreatment in a rat model of intestinal ischemiareperfusion injury: a histomorphometric study. Clinics 2007; 62: 315–320.
28. Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013 Aug 15;9(1):30.
29. Shernan SK. Perioperative myocardial ischemia reperfusion injury. Anesth Clin North Am 2003; 21: 465-485.
30. Laschinger JC, Cunningham JN, Cooper MM, Krieger K, Nathan IM, Spencer FC. Prevention of ischemic spinal cord injury following aortic cross-clamping: use of corticosteroids. Ann Thorac Surg 1984; 38: 500-507.
31. Tabayashi K. Spinal cord protection during thoracoabdominal aneurysm repair. Surg Today 2005; 35: 1-6.
32. Laffey J, Boylan J, Cheng D. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215-52.
33. Ondiveeran HK, Fox-Robichaud A. New developments in the treatment of ischemia/reperfusion injury. Curr Opin Investig Drugs. 2001;2(6):783-91.
34. May MJ, Ghosh S. Signal transduction through NF-kappa B. Immunol Today 1998; 19: 80-8.
35. Nakamura T, Goto M, Matsumoto A, Tanaka I. Inhibition of NF-κB transcriptional activity by α-tocopheryl succinate. Biofactors 1998; 7: 21–30.
36. Walker MK, Vergely C, Lecour S, Abadie C, Maupoil V, Rochette L. Vitamin E analogues reduce the incidence of ventricular fibrillations and scavenge free radicals. Fundam Clin Pharmacol 1998; 12: 164-172.
37. Venditti P, Masullo P, Di Meo S, Agnisola C. Protection against ischemia-reperfusion induced oxidative stress by vitamin E treatment. Arch Physiol Biochem 1999; 107: 27-34.
38. Bradley D, Bueno M, Bueno R, Chambers C, Neumeister MW. The Effect of Vitamin E Succinate on Ischemia Reperfusion Injury. Hand 2010; 5: 60-64.
39. Günel E, Çağlayan F, Çağlayan O, Dilsiz A, Duman S, Aktan M. Treatment of Intestinal Reperfusion Injury Using Antioxidative Agents. J Pediatric Sur 1998; 33: 1536-1539.